What is VXRT's P/E ratio?

VAXART INC (VXRT) currently trades at a P/E ratio of 2.49.

VAXART INC reports a Return on Equity (ROE) of 39.42%.

What is VXRT's dividend yield?

VAXART INC offers a dividend yield of 0.00%.

What is VXRT's Deepscope Quality Score?

Deepscope rates VXRT's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VXRT?

Deepscope's AI Timing Score for VXRT is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VXRT belong to?

VAXART INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

VXRT (NASDAQ) Stock Analysis | VAXART INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-04 | FS: 2026-03-31)

VXRT

VAXART INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 94

USD 0.62

0.02 (3.32%) Day Change

Watchlist Portfolio Compare Chart

2.49

P/E

0.03

D/E

39.4%

ROE

20.6%

ROA

0.00%

Div Yield

-0.04

PEG

VAXART INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.62 Price 0.02 (3.32%) Day Change	NEWS SCORE: 94

VXRT, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

58%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	199
Magic Formula Rank by ROE	199
Magic Formula Rank by ROIC	101
Price	0.62
PBV / Sector	1.59 / 4.63 GOOD
Earning Per Share	0.15

PE / Sector	2.49 / 17.43 GREAT
PEG or PE/Growth / Sector	-0.04 / 0.53
Average 1M Daily Value	0.13 M GREAT
Average 1W Daily Value	0.09 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	14.51 / 449.48
NPM Average (%) / Sector	-20,407.57 / -1,506.49
NPM Change Average (%) / Sector	-42.52 / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	20.60 / 30.58 GOOD
ROA Average (%) / Sector	-34.14 / -347.17
ROA Change Average (%) / Sector	-3.49 / 5,125.52
ROE (%) / Sector	39.42 / -3.58 GREAT
ROE Average (%) / Sector	-59.14 / 40.65
ROE Change Average (%) / Sector	5.41 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

Registration Details

Analyze Date	2026-06-06 09:09:19
Symbol	VXRT
Name	VAXART INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	242.04 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	150.07 / 8,857.28

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 310 Utah Avenue, South San Francisco, CA, United States, 94080

Phone: 650 550 3500

Website: https://vaxart.com

Employees: 65

Sector: Healthcare >> Biotechnology

Description: Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome coronavirus; Seasonal Influenza vaccine, which is in Phase 2 clinical trial, to treat H1N1 Influenza; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. The company also provides VAAST (Vector-Adjuvant-Antigen Standardized Technology) Platform, a unique modular vaccine platform. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.